Epidemiology and Health Care Research
Program area 2
This programme area investigates clinical, social and biological factors influencing the course of rheumatic and musculoskeletal diseases (RMD), the long-term safety and effectiveness of therapies and the adequacy of health care for persons with RMD. Research aims to improve the quality of life of children and adults suffering from rheumatic diseases, make treatment safer and address gaps in health care. Research is based on large longitudinal cohort studies carried out in close cooperation with more than 500 paediatric and adult rheumatologists.